Digoxin vs Upadacitinib
Digoxin vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Digoxin and Upadacitinib.
Mechanism of Action
Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Digoxin β 36-48 hours; Upadacitinib β 9-14 hours.
Chemical Properties
Molecular Formula: Digoxin β C41H64O14; Upadacitinib β C17H19F3N6O.
Molecular Weight: Digoxin β 780.9430 g/mol; Upadacitinib β 380.3700 g/mol.
Type: Digoxin β Small molecule; Upadacitinib β Small molecule.